The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great ...
The FDA has granted approval to sevabertinib (Hyrnuo) for the treatment of patients with locally advanced or metastatic, ...
Embryonic stem cells are powerful tools for understanding how organisms develop and how tissues regenerate. These cells have ...
The CRISPR Cas9 gene editing tool — the genetic scissors that won the 2020 Nobel Prize in Chemistry — is essentially based on ...
Sickle Cell Disease, a severe genetic blood disorder, disproportionately affects India’s tribal population, particularly in ...
CRISPR Therapeutics is the subject of strong buyout speculation after earning FDA approval for a breakthrough gene-editing ...
Union Minister of State (Independent Charge) for Science & Technology; Earth Sciences; MoS PMO, Personnel, Public Grievances, ...
In a step towards eliminating sickle cell disease, which disproportionately affects India’s tribal population, the government ...
Bayer’s sevabertinib picks up a second-line indication for HER2-mutated disease, joining Boehringer’s zongertinib on the US ...
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now ...
New research shows a therapy that’s been used for cancer patients may help people with lupus go into remission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback